Company registration number.. 10089069
Charity registration number. 1166416
Hannah's Willberry Wonder Pony Charity
IA Company limited by guarantee)
Annual Report and Financial Statements
for the Year Ended 31 March 2024

Hannah's Willberry Wonder Pony Charity
Contents
Trustees. Report
110 11
Reference and Administrative Details
10
Independent Examinerfs Report
12to13
Statement of Financial Activities
14
Balance Sheet
Statement of Cash Flows
Notes lo the Finanaal Statements
171023

Hannah's Willberry Wonder Pony Charity
Trustees, Report
Thè trustees, who are directors for the purposes ol company law, presenl the annual report together
with the financial slalements of the Charitable company for the year ended 31 March 2024.
Oblectlvès and aetlvltlgs
Ourpurpose
Hannah's Willberry Wonder Pony Charity seeks lo provide a public benefit by..
promoting research into the causes, prevention and treatment of bone cancer and other ty￿$ of
ancer-
promoting the hgallh and wellbeing of people with a disabS11ty or serious Illness., or, ptrople who are
affected by the disability or serious illn855 of a close family member., or, people who are suffering from
bereavement following the death of a close family mernber, by providing or assisting in the provision
of opportunilies to ride or enjoy other equestrian related experiences-, and
assisting in the treatmènt and care ol pgopI8 suffering from bone cancgr and other types of cancer
and to help people caring for them.
The Charity can provide:
grants lo organisalions carrying out research into bone cancer. provided that the results of the
research funded will be published. In the event that the Charity is not the sole funder of any research
then the grant of funding will be subject lo a Condition that res(>lts of resoarch will be published and
available for general use-
grants lo organisalions, indiwduals and their families lo assist those affected by bone cancer and
other types of cancer..
an experience of an equestrian naturo our Willberry'5 Wishes team. making precious memories
to treasure forever.
Ba¢kgmund
Hannah Francis founded the Charity, Hannah's Willberry Wonder Pony. in March 2016, having been
di8gnosed with 051eosarcoma the year before al just 17 years old. She wanted to leave a legacy and
help people like her who are affected by a serious illness and wanted the Charity lo raise money to
fulfil ￿0 principal objectives.. lo fund research into osleosarcoma I'willberry's Research),. and to
provide equestrian experiences to seriously ill people and their families 1"Willber￿S Wishes"). The
Charity went from strength lo strength under Hannah's leadership and has continued lo grow sinc8
her passing in August 2016, raising more than £2 million lo dale. The Charity has funded a number of
significant research projects as Hannah so dearly wished,. she fought so courageously and endured
such archaic treatment that she never wanted anyone else lo have lo go IhrL)ugh thi5. Hannah lived
lor her horses and whilst she was ill. she licked many equine dreams off her bucket list, and gave her
the inspiration for "Willberry's Wishes.. The Charity is granting Willberry's Wishes lo seriously ill
people in the hope that these 8xperiances inspiro others in the same way as they did Hannah,
bringing a little happiness and hope during the dathest of limès.
Pag8 1

Hannah's Willberry Wonder Pony Charity
Trustees, Report
We the Trustees are grateful lo the thousands of people who have helped with donations, fundraising
and spreading the word about Hannah's Willberry Wonder Pony Charity.
When necessary, the Charity engages the services of experts to assist wilh the running of the Charity
but for ihe vasl majority of the time It has been run by volunl8ers. including the Trusleas, and we arts
very proud of &veryone's efforts in keeping the cost of running the Charity to a minimum and thus
ensuring maximum funds are available lo apply lo public benefit. However, the need for sorneone lo
manage the Charity on a day lo day basis is currently under review to ensure that the Charity
continues lo run professionally, efficiently and maximises ils public ben8fil. We are grateful lo our
volunleers for th8 finan¢ial prot8ction they give us by giving n)any hours of their time, as wtsll as
opening their homes for meetings and providing storage space for our traLling sub5idiarls
merchandise stock.
Our Activities During 2023124 and Achievements to Oat
We believe that the Charity has provided a public benefit in the following ways..
In our eiglh full year as a charity we have raised funds of £83,630 Iprevious year a deficit of £5,880)
on income of £156,509 (previous ye8r £103,613). Thi5 Was another Successful year in terms of funds
generation, with fundraising efforts delivering good growth in income. We are incredibly grateful for
the fabulous fvndraising efforts and donations from so many of our supporters. We also rec8ived
gengrous donations from individuals, trusts and other charities. The money raised wll help to providè
funds lo meet the Charills objectives and provide public benefit in the years lo come by helping fund
bone cancer research and providing Willberrfs Wishes.
The trading subsidiary. which sells Willberry branded rnerchandise and donates all of its profits lo
the Charily1£24,438 In 2023124, p￿vIOuS year £12.8371 has had another successful year. Demand
remainèd steady for our Berry Ponies for other items which were also sold al equestrian events
including Badminton Horse Trials, where some riders still lake lo the cross-counlry course with their
berry pony strapped lo their backs, thus giving the Charity continued and valuable public profile. The
portfolio ol branded items offered is wnstantly reviewed lo ensure Ihal we keep our followers happy
and achieve the be51 financial outcome.
During the year, we have provided a numbar of Willbery's Wishes to people who are fighting, or ar8
affectgd by, serious illness. Spending during the year providing these experfences amounted lo
£2,250 which included..
A wondorful day at the phènomenal Badminton Hors8 Trials for a k)vèly young lady and her friend.
They were wined and dined and had a full day of equestrian magic, especially as il was cross country
dayl We even arranged a surprise meeting with Olyrnpic rider, Torn McEwen. who then look them into
the presligiDUS stables on the Badminton Eslale where they mel some very famous horses indeed.
A special visit from a shetland pony lo meet a very poorly little gid in the hospice.
Some carriage driving lessons were arrang&d for a lady who had breast cancer. This is something
she had a￿ayS wanted to do. and she had the most amazing experience.
"A magical day for a littlg girf wff(h her siblings. a pony play day - Doris, Hannah's Shetland and a
small pony for the other children travelled lo meet the family. Lols ol cuddles, grooming. riding and
even some racesl Followed with a picnic fea51.
'Pony Fun Day for a brother and sister at a riding school. They gol lo ride a number of ponies and
even had a go al mounted gamesl 11 was lovely as they were wlh lols of other children who wtsre a
similar age.
'A special little girl had a￿ayS wanted lo leam lo ride so we arranged for a set of riding lessons so
sh8 could fulfil her dream.
Page 2

Hannah's Willberry Wonder Pony Charity
Trustees, Report
Wg are extremely fortunate Ihal many wonderftjl people in the equestrian community assist us in
providing Wishes al no charge lo the Charity. Since form81ion, many Wishes have been granted and
all of these have been very well received by the recipients and we look forward to providing many
more.
In rgspoct of medical research, we have in place an expert panel to assist the Trust88s In seleeling
and analy5ing bontr cancer research projects. The expert panel is headed by Dr Claire Clarkin,
Associate Professor of Developmental Biology, University of Soulhamplon. and she is very ably
assisted by Dr Alice Goring, who completed a PhD related to Ihe study ol the role of blood vessels in
bonè diseases. and they both provide critical assistanc8 lo the Charity in managing the medical
research investment process. Wa have continued lo meet a number of clinical and academic
specialists in the fi8ld of osteosarcoma research and have made significant progress in increasing the
profile of the Charity in the academic and scientific communities, including advertising for PhD
studentships wth major universities.
As a major milestone and lo mark the in¢redible progress made lo dale, we htsld the fir51 Hannah's
Willberry Wonder Pony Charity Research Symposium on Thursday 5th October 2023 in London. And
this was no ordinary venue, as we were so fortunate to be able to hold the event al The Goring Hotel,
thanks to Hannah's close friend land member of our Research advisory panel), Dr Ai¢e Goring, who
also did an amazing job organising lh& day. We welcomed researcher5. 5UPPOrter5 and friends from
across the UK for 8 day of osleosar¢oma experiences. Science and discovery. Rachel Francis started
the day by telling Hannah's story, from her time as a pony-mad young girl and hugely talented ridar
through to her initial symptoms, incorrect diagnoses and tha simply dreadful day when Hannah and
her family first heard the word 'osteosarcoma'. She spoke movlngly about every stage of the
Irealmenl Hannah endured and the horrifi¢ side effects and lack of hope. And Rachel finished by
bringing lo life Hannah's passionate desire lo help others and her enduring positivity and love of life. It
was a perfect way lo sel the context for the day that followed because, above all. she highlighted the
desperate need for the scientific research Hannah's charily is funding. 11 also reiteraled so articul8lely
why Hannah is always at the front of our minds when we are all trying so hard lo fulfil her rich legacy.
This was followed by an equally absorblng talk by Dr Polly Bales. Hannah's clinician al Royal United
Hospital in Bath. Polly spoke in glowing terms about Hannah's fortilude and endurance, but brought
starkly to life the desperately poor treatment outcomes that so many bone cancer patients face. Polly
was followed by Matt Clark, who suryived his diagnosis of osteosarcoma when in his late teens. Matt
explained how luck played a part in his own diagnosis and Irealmenl and he not only brought further
context to why we were all assembled but he has also pledged to help Hannah's charity with a bold
fundraising plan for 2024. We then had a busy day of excellent talks from all our PhD projects and il
was great lo hear all about th8ir research progress. We also had some more In-depth talks from
prominent research leaders, including Profe550r Agi Grigoriadis IKing College London), Dr Helen
Roberts (Middlesex University) and Professor Allie Gartland (University ol Sheffieldl, who talked about
her team's work with large scale drug screening for new treatments in osteosarcoma, which is funded
by the Charity. Our first Research Symposlum was a very emotional but Inspiring day and a
lebration of the collective hard work that is ongoing into funding and advancing osteosarcoma
Iroalments.
Paga 3

Hannah's Willberry Wonder Pony Charity
Trustees, Report
In total to date, we have identified and committed to ten research projects from leading English
Universities that w& are supporting with a combined valug of up lo £933.607. of which £57,323 was
spent in the financial year. We are confident that in the coming years we will identify projects from
other inslilulions that will assist in the idenlificalion of the causes, prevention and Irealmenl of bone
cancer and other types of cancer. These efforts will be significantly enhanced by the recent
announcomenl that the Charity will bo working logether with The Bone Cancer Rgsear¢h Trust to offar
funding of up to £250,0001£125,000 fundtsd by each charity) to support projects focused on improving
outcomes for osteosarcoma patients.
The lead time for identifying, reviewing, approving and funding research projects remains up lo 2
yaars. The Trusle8s arè very ¢ons¢ious of th8 need to sè16Ct prospéctive resèarch projects carefully
and lo ensure the Charity's money is investèd In a consid8red and approprlale way.
Our Strategy Going Forwards
The Trustees continue lo review the strategy of the Charity lo ensure that il provides public benefit
and has the ability to meet its objectives. The Trustees are hopeful that income generated in 2024125
will meet our targ&t of £100.000 and this, 109ether with our strong reserves, will onable us lo carry out
the Charity's objectives in futur8 years.
As mentioned above, the Charity has since formation entered into, or is about lo enter into,
agreements lo furid len research projects.
Thg projects that we have funded, or are currently funding, are listed below-.
oThe first is with the renowned Department of Oncology and Metabolism al Sheffield University which
ran until the end of 2023, with a totsl cost of up to £210,000. The project can be summarised as
follows..
As a result ol fundlng from WlllberTVs R&sear¢h, a team comprising a Post-Docloral Researcher
(Luke} and a Ipart fundedl PhD Sludenl Iviclorial, led by Professor Alie Gartland, is lesling over
5.000 existing dTU9S and compounds lo assess their effectiveness in killing osteosarcoma cells. The
team hopes lo identify polentially useful new drugs and pathways lo develop more effective
treatments to improve pabenl respons6s. Because the drugs being s¢reened have already been
approved for huinan use, the idenlificalion of new drug candidates could potentially b8 more timely
and reach the clinic in a much shorter lime as a result.
The main current therapeutic approach for osteosarcoma is a combination of methotrexate,
docorubicin, Cisplatin, andlor ifosfamide associated with surgery. Unfortunately, not all patients
respond lo these chemotherapy drugs, as their tumour becomes 'chemo-resislanl' and their overall
year sutvival rate is drastically redLJcèd. The need for alternative, more effective treatments lo
ncrease the survival rates of osteosarcoma patients is cl8ar. The scientific team being funded by
Willberry's Research is using 'High Ihroughpul screening, lor HTSI of compound 'libraries' to identify
whether existing drugs can be used in osteosarcoma.
Excitingly, out of the 4,400 drugs which have been Screened so far, 550 have been found lo have a
negative effect on the growth of osteosarcoma cells Igrowng in a dish) at high doses.
Page 4

Hannah's Willberry Wonder Pony Charity
Trustees, Report
o The Charity has also part-funded a PhD student al, Sheffield University, Manchester Univtsrsity and
vo at the University of Soulhamplon, with a eornbined funding of £183,000 over 3 years. All four
projects were focussed on Osleosarcoma.
o Hannah Smith was our first PhD slud6nl and bas8d at Southampton University &upetvised by Prof
Stephen Beers Dr Juliet Gray snf Dr Janos Kanzcelr. Osteosarcoma is the most common bone
sarcoma in adolescents and has a poor outlook. Novel Irealmenls for this POOTly mel patient group are
¢learly needed bul their development is hampered by the complexity of the disease and the
environment in which il grows. Hannah was developing 3D models of osteosarcoma to gain a better
understanding of the inlera¢lions between the os180s8rcoma tumour and its SLJrrounding ènvironment.
Osteosarcoma is an in¢redib5y Complex type of cancer and currently very little is known about the
environment in which it grows. This project focused initially on the drug mifamurtide (also known as
Mepactl which is used in palienls, bul to which not all respond. to understand how this drug works
and potentially how lo make il work bell6r in more patients. Her PhD is lo develop a 3D model of
osteosarcoma, which will enable the testing of new drugs and Ihorapies. This is done by using bone
from patients who have had hip replacement surgery and inserting osle05arcoma cells into thesa
bone cores. These cores are then positioned to enable blood vessels to inleracl with the bone, so that
osteosarcoma ¢8lls remain alive, and the effe¢l of different therapies can be tested.
o Another project at Soulhamplon UnNersity, with Belle Creilh a5 a PhD student, started in October
2019 and was supervised by Dr Claire Clarkin, Professor Richard Oreffo and Professor Sumeet
Mahajan. This was focused on the earfy delection of osteosarcoma, which is so important, as we are
only loo aware how quickly this cancfjr can sprgad. The project has b88n using some very advanced
imaging techniques lo look al the fibrès which are prtssenl wilhln osteosarcoma and healthy bone
biopsies. Belle is looking al whether diff8rences in these bone fibres in diseased versus healthy bone
might be early indicators for osteosarcoma and a measure of meiaslasis. There have been some
really good images and findings so far and results of this project should be published soon.
o And our PhD project with Manchester University, which also started in October 2019, builds on the
success of an earlier ￿0-year research grant funded by the charity, Friends of Rosie Children's
Cancer Research Fund. In common ¥Mth the initial project, our project is being led by Dr Katherine
Fineg8n, MRPharmS, with Alex, our PhD sludenl. Pfevious work performed in this lab has found that
protein called ERK5 can promote the progression of 051eosarcoma.11 has alsts been found that high
levels of the ERK5 protein can increase the chances of chemotherapy resistance and the spread of
osteosarcoma around th8 body. Therefore. highèr levels of ERK5 are linked to a reduced chanc8 of
survival in patients. Initial evidence has found that. by removing ERK5. lumour cells and immune cells
are no longer able lo cornmunicale with each other. This is really p0511ive data from thi5 lab group as it
is the communication between the lumour cells and the immune cells which allows the cancer lo
spread around the body. 11 is Currently unknown how this happens, but removing ERK5 has shown lo
slop the spread of canGer lo the lungs in models of the disease which have been used in the lab. 11 is
really important to fully understand how this happens in order to effectively treat osteosarcoma and to
develop this treatment for patient use in Ihe future. This projecl aims to find out exactly how ERK5
works in the progresslon of osteosarcoma and determin& whtslher removing ERK5 can improve the
response to chernolherapy. This is a promising new avenue for the treatment of osteosarcoma.
o Another of our projects is a first fully-fundg(J PhD sludenlship, based at Middlesex University within
the Centre for Investigative & Diagnostic Oncology. The resear¢h, led by Dr Helen Roberts (Senior
Lecturer), aims to unravel the cornplex cellular and environmental control of how osteosarcoma, the
rare type of bone cancer the Charity is focused on, spreads to other tissu8s such as the lungs.
Page 5

Hannah's Willberry Wonder Pony Charity
Trustees, Report
For the past 30 years. survival rates in osleDsar¢r)ma patients have remained unchanged. partly due
lo the lack ol rosearch into why the lumour spreads and wh81 initiates this process. Preclinical and
clinical ewdence highlights that osleos8r¢om8 lumours likely reside in the bone environtnenl due lo
'proleclive' inleraclions with bone cells. 11 is hypolhesised that disruption ol these protective
interactions causes the lurnour to move from the bone lo the lungs in a process called metastasis.
The project is investigating why osteosarcoma tumours metastasiso to the lungs and is Ljsing cutting
edge ¢ell-based assays lo define not only the role of the bone ce115, bul also the lung environment.
The project draws on the tissue engineering experience of Dr Scott Roberts Isenior Lecturer in
Tran51alional Skeletal Research, RVCI, who has spent over a decade developing laboratory grown
tissues Ihat can be used for regenerative medicine and the investigation of disease processes. Here
is an update from our res8ar¢her'.
"Our project aims lo identify how 051eosarcoma cells spread lo other tissues such as the lungs. We
have identified spheroid-like structures formed from osteosarcoma cells which we have termed
'Migralory Bodies,. These Migratory Bodies divide, reattach. and express increased gene expression
of st8m cell markers. sugg&sting that they contain tumour inilialing Ican¢er slèml cells and are
therefore an ideal model for sludwng how osteosarcoma ctslls spread lo other 11sSUtrS.
We have also looked al the effect of secreted factor5 from two types of bone cells on osteosarcoma
cell migration. The data show Ihal when osteosarcoma cells are cultured with factors secreted by
osteoclasts (cells that break down bonel and mesenchymal slromal cells IMSCS,. ¢&lls wilh Ihe unique
abilily lo develop into specialised cell types). Migratory Body fomalion is suppressed. Thus, we
believa that both MSC5 and osleo¢l8s1s secrete factors that modulate Migratory Body formation and
thus osteosarcoma cell rnigration. By investigating these findings further, we hope to understand
some of the mechanisms that allow osteosarcoma to spread to other tissyes..
o In addition. we are currently funding a PhD project wth Kings College London This is a Ihree-year
research project which is taking place under the expert guidance of Professor Agarnemno
Grigoriadis. The project is focusing on understanding and preventing the growth of cancer cells in
osteosarcoma patients. as well as looking to stop the spread of cancer around th6 body. The ability of
osteosarcoma to m&taslasise is what makes il so aggressive and therefore focusing the research on
this is really important. This project 15 looking al repurposing a prtrexisling drug, which is currently
used lo Ireal neonatal jaundice, lo block the action of F+O-1. HO-1 is a factor which is produced by
osteosarcoma patients and prevents the activation of the immune syslem. By 'kick-starting' the
immuno system inlo a¢lion, the project will assess il Ihe chemotherapy dwgs are able lo fight the
cancer and slop il from moving to other areas of the body.
o The Charity has recendy invited follow-on projects from the initial tranche of resgar¢h idgntified
above and we are pleased lo confirm 2 four-year PhD sludenl grants have been awarded for a lolal
value of £245,000. The projects are..
o Middlesex University {Dr Helen Roberts) - lh8 reS9a￿h projgct entillgd Suppress Osteosarcoma..
Targeting 0steoclas1-Tumour Interactions to suppress Osteosarcoma metastasis. There is a
hypothesis that Osteosarcoma establishes itself in bones by interacting with osleoclasls. specialised
cells responsible for breaking down bone tissue. Disrupting this interaction allows OS lo spread to the
lungs. In our prior study, we identified 'Migralory Bodies, IMBS) as 8 valuable laboratory model for
sludwng OS spread. Osleoclasl factors slow down MBS, bul the drug zoledronic acid (used lo Ireal
osleoporosisl can counteract this effect. In the proposed study we will use genetic engineering. to
unravel how OS spreads, with a particular focus on polenlial Irealmanl tsrgels STAT3 and MMP9.
Additionally, we plan to examine OS rnetabolism and employ a unique model to enhance OL+r
understanding of melasiasis. This research holds promise for refining OS Irealmenl slralegies,
incorporating insighis into osteoclast interactions, wilh the ults'male goal ol improving oul¢omes for
patients.
Page 6

Hannah's Willberry Wonder Pony Charity
Trustees, Report
o King5 College London IProfessor Agamemnon Grigoriadisl - a Novel FGFR-HO-1 Axis for Targeting
Osteosarcoma Palhogenesis and Melaslasis. Osteosarcoma 15 a devastating malignancy that affects
Children. Metastalic disease remains the most important prognostic indicator of survival, and despite
advanc8s in adjuvant chemotherapy and limb-sparing surgery. 5-year survival is 60-70%, dropping lo
-200/0 with metaslali¢ disease, and these frequen¢i8s have not improved. We have malle recent
progress from an ongoing HWWPC-funded project that is idenlfying a novel largel for OS melaslasis
therapy. The enzyme. HO-1, is made by cells in the lumour immune environment Ihal are normally
hijacked by tumour Cells lo evade the immune system. Using a drug called SnMP that slops HO-1
from working, this reduces OS melaslasis in m(>dels by reactivating the immune system. enabling
killing of lumour ce115. The ¢urrenl HWWPC proposal aims lo follow on from this work, lo show that
this HO-1 pathway interacts with a target in lumour cells themselves, called FGFR. We have shown
thal blocking FGFR in tumour cells can inhibit melaslasis but whether this affects the inlera¢tion of
lumour cells with th8 mi¢roenvironment is not known. This project will ostablish for the first time
whether these pathway5 communicate and cooperate with each other lo drive OS mela5tasis. This
will open the door lo novel combinatorial therapies using multiple drug combinatsons that will reduce
metastatic burden and increase patient Survival.
o In addition the Iruslees are excited to confimi that the Charity will be working logglher wlth The
Bone Cancer Research Trust lo joint fund a posldocloral 3 year research project of up to £250.000
1£125.000 lunded by each charity) in the 2024125 academic year with Imperial College London led by
Dr Jun Ishihara lo support projects focused on improving outcomes for osleDsarcoma patients.
Treatment for osteosarcoma has not changed for several dacadas and still relias on a cocktail of toxic
¢hemotherapies. New, largeled Irealmenls, with less immediate and long-lem) effects are desperately
needed lo ensure mor8 patients survive and thrive after treatment. Imrnunotherapy is emerging as an
effective treatment in many Can￿r$ and works by helping the immune system find and attack cancer
¢811s. With Ireaimenl options for osteosarcoma patients remaining unchanged for decades il's vital
that we investigate options such as immunotherapy for our palianls and try lo translatè the progress
being made in other cancers to osl&osar¢oma. We're delighted to be able lo do this in collaboration
with the Bone Cancer Research Trust who wholeheartedly have the same aim as LSS. to offer
osteosarcoma patients kinder and more effective treatment options..
o A protein named inl&rleukin-12 IIL-121 is known lo successfully aclivale anli-lumour immune ceSls
against several cancers. However, despite showing sliong antilumour a¢tivily, IL-12 also induces
severe toxicity lo other tissues. Dr Ishihara has successfully been able lo redu￿ IL-12's toxicity by
incorporating an addibonal fragment Itumour-largeled domain - TTDI to the IL-12 protein thal enables
ils delivery selectively to the tumour, ThD-IL-12 a¢¢umulales in the lumour due lo the targeted protein
being present in the lumour's blood vessels. TTD-IL-12 is effective in laboratory models for other
cancer types and in initia1 osteosarcoma laboratory models. This project aims lo extend the results
found in other Cancers to a full range of laboratory models of osleosarcoma. The research also aims
to delerrnine if a ¢ombinalion ol TTD-IL-12 wrth doxorubicin {part of the current MAP chemotherapy
regimel can offer additional benefit.
In respect of Willber￿S Wishes, th8 Charity has a small team of volunle8rs ¢Jedicaltrd to helping
organise and provide these equestrian-relaled Wishes. Interest is growing and is expected lo continue
to do so, as word has spread about how we can help seriously ill people and their families during the
darkest of limes by giving them experiences to look forward lo, whilst making memories for all those
involved. We share details of some of the vital Wishes we grant, bul other recipi8nls understandably
wish to keep them private. We are immensely grateful for the continued support of so many pgople
and organisalions in the equestrian worfd, as this is critical in supporting our ability lo provide
Willberry'5 Wishe5.
Willberry's Wishes helps so many people, not only the Wishee bul also their families, and we alway5
have a number of Wishès that we are working on.
Page 7

Hannah's Willberry Wonder Pony Charity
Trustees, Report
.Willberry's Wishes is about making memories, giving people things to look forwar(S lo and lo for9el
yvhal is happening lo them even if it is just for a little while. We hope lo help lols of people by grants'ng
many more Willbery's Wishes.
Financial review
The following section on Financial Review and Future Developments const'tules the Slrateglc Report
for Ihtr purpose5 of the Companie5 Act 2006 and the Iruslees confirm that they have complied with the
requirements of section 4 of the Charities Act 2011 to have due regard lo the public benefit guidance
published by the Charity Commission for England and Wales.
In its eighth year of opgralion, the Charfty generated a surplus of £83,630 (previous year a deficit of
£5,8801, all of which were unreslricled fund5.
The Charitys main Source of finance is donations. with a Signifi￿nt ¢onlribution also being made from
the trading subsidiary.
Re5erve5 policy
The Trustees of the Charity have reviewed the Charivs reserve5 policy in line wlh the existing
commitments and intended future commilmenls lo osteosarcoma research, Willberry's Wishes and
estimates of future administration costs. At 31 March 2024. resfjtves stood at £1,618,9871£1,535,357
in the previous yearl which was subslanlially more than the amount required lo meet these
commilmenls. These funds are held in low risk deposit accounts with various financial inslilulions.
As previously highlighted, the Charity has committed to date lo expenditure on len osteosarcoma
research projects with a value of £933,607, of which £516,137 has b8gn sp8nt and the balance of
£417,470 is committed expenditure over the next 4 years.
The Charity is cU￿entlY in the prO￿sS of preparing for the invitation of applications for ftjrther project
funding requests from the research community, with the aim of awarding more lully funded research
projects. It is anticipatèd ihat there will be at least 2 new projects costing a Combined £250.000 lover
4 years) Committed lo in each of the next 3 years.
In addition. as sialed above, the Trustees are excited to confirm that the Charity wll be working
together with The Bone Cancer Res8ar¢h Trust lo offer funding ol up lo £250.000 (£125,000 funded
by each charity) in the 2024125 acad8mic year lo support projects focused on irnproving outcomes for
osteosarcoma patients.11 is anticipated that this working relationship will directly lead to further
research opportunities in futur8 years with the aim of wmmitting to further larga Icir¢a £250,000)
projects, jointly funded circa £125.000 by each charity.
In addition the Charity wll continue to fund Willberry's Wishes.
Conclusion
The Trustees believe that the Charity has, through the kind and generous help of our supporters and
volunteers, raised funds that will provide a public benefit in years to come through the funding of bong
cancer résearch and tho provision of Willberry's Wishes.
Pa9e 8

Hannah's Willberry Wonder Pony Charity
Trustees, Report
Stru¢tur8* governanca and managernent
Nature of governlng document
The company is a registered charity, number 1166416. and was incorporat8d on 29 March 2016. It IS
govemed by the articles and memorandum of association of that date.
Thg company is limited by guarantee and wilhoul a share capital. Al Trustees are members of the
CO￿panY and guarantee to contribute to the assets of the company, in the evenl of il being wound up,
such amounts as may be requir￿ not exceeding £10.
Our Trustsès
The Charity is currently run by S Iruslees, including Hannah's parents (Rachel and James Francis)
and her grandmother lJune Clolhierl. The other two Trustees are lan Pelers, former Financial
Controller of Hanson plc. General Manager of Hanson Europe and Finance Director of Breedon
Aggregaltrs PLC, and Miles Toulson-clarke. a former Main Board Director of Williams Lea Group and
currently UK CEOIGroup COO of Innovation Group and Dislri¢t Commissioner of the Wylye Valley
Pony Club. Each of the Trustees gives their time freely. both in their roles as Trustees and carrying
out day lo day iasks in running the Charity.
Day to day aclvllles of the Charfty aro delegated to each of the Trustees on a fijnctional basls as
follows.. Rachel FranGIS
first point of contact. Willberrfs Wishes and fundraising and research.
James Francis
Willberrfs Wishes, media and communications and research., June Clothier
trading subsidiary sales including online and at events and research,. Miles Toulson.Clarke- resfyarch
and media and communications., 18n Peters- finance and legal.
Induction and training of trustees
Before being appointed, a potential new Iruslee is encouraged lo attend a number of Iruslee meetings
to familiarise themselves with the work of the Charity. A newly appointed Iruslee Teceives guidance
and infom)al training lo enable them lo perform their duties effectively, including governance and
management, an induction to Ihg history and current activities of the Charity, code of conduct and
charity ethics. New Iruslees are provided with ¢opies of key documents includin9 the Charivs
goveming documents, rninules ol recent Iruslees meetings and, once these are available, the latest
sel of financial statements and trustees, report.
Flnan¢lal In$truments
Objectlves and pollcles
The Charills activities expose ft lo a number of financial risks, principally liquidity. The Charity does
not use derivab've financial inslrumenls.
Page 9

Hannah's Willberry Wonder Pony Charity
Trustees, Report
Liquidity risk and interest rates
The Charitls principal financial assets are bank balances and cash. trade and other recèivables, and
inveslmenls.
Thtr credit risk on liquid funds and derivative financial inslnjmgnts is limited because the
counterparties are banks with high credil-ralings assigned by intemalional credil-raling agencies. The
Charity has deliberately taken a conservative approach lo investing its available funds during the
course of the financial year which, given the current international interest environment. has generated
a low ralg of return. There is some residual risk lo the Charity should interest rates turn negative.
In order lo maintain liquidity lo ensure (hal sufficient funds are available for ongoing operations and
future developments, the Charity has adopted a conservative reserves policy.
Reference and Administrative Details
Truste8s
J S Clothier
J R Francis
R Francis
l A Peters
C T M Toulson-clarke
Charlty Registration Number
1166416
Company Registration Number 10089069
The chanty is incorporated in England and Wal8S.
Manor Fami
Hemington
Radstock
BA3 5XX
Reglstered Offi¢e
Independent Exarniner
PaLJI Giessler FCA
Francis Clark LLP
Hil¢hGock House
Hilltop Park
Devizes Road
Salisbury
SP3 4UF
Tho annual report was approved by the tntrstees of the charity on
behalf L)y'.
ID
and signed on ils
IAP
lers
Trustee
Page 10

Hannah's Willberry Wonder Pony Charity
Trustees, Report
Statement of trustees, responsibilities
The trustees (who are also Ihtr directors of Hannah's Willbtrrry Wonder Pony Charity for the purposes
of company lawl are responsible for preparing the Iruslees, report and the financial slalements in
accordar)ce with applicable law and United Kingdom Accounting Standards Iunited Kingdom
Generally Accepted Accounting Praclicel, incsuding FRS 102 "The Financia1 Reporting Standard
applicable in thg UK and Rèpublic of Ireland..
Company law requires the trustees lo prepare financial slalemenls for each financial year. Under
company law the truslees must nol approve the financial slalements unless Ihey are satisfied that
Ihoy giv8 a truè and fair viaw of tha state Df affairs of thg charitable company and of the incoming
resources and application of resources, including ils income and expenditure, of the charltable
company for that period. In preparing these financial stalemenls. the trustees are required to=
select suitable accounting policies and apply them consistentty;
observe the methods and principles in the Charits'es SORP.,
make judgements and eslimales th81 are reasonable and prudent.,
state whether applicable accounting standards, comprising FRS 102 have been followed, sublecl
lo any material departu￿$ disclosed and explained in the financial slalernenls., and
prepare the financial slalemenls on the going concern basis unless il is inappropriate to prgsume
that the charitable company wll continue in business.
The Iruslees are responsible for keeping proper accounting records that can disdose with reasonable
accuracy al any lime the financial position of the charitable company and enable them to ensure that
th8 financial statements comply with the Companies Act 2006. They are also responsible for
safgguarding the assets of the ¢haritable company and hence for taking raasonable steps lor the
prevention and delecllon of fraud and other Irregularities.
The trustees are responsible for the mainlenance and integrity of the corporate and financial
infom)ation included on the Charitable companls website. Legislation goveming the proparalion and
dissemination of financial statements may differ from legislation in other jurisdictions.
Approved by the trustees of the charity on
and signed on ils behalf by..
IAP
Trustee
P8ge11

Hannah's Willberry Wonder Pony Charity
Independent Examiner's Report to the trustees of Hannah's Willberry
Wonder Pony Charity ('the Company,)
I report lo the charity trustees on my examination of the accounts of tho Company for th8 year ended
31 March 2024.
Responsibilities and basis of report
As the charity's IDJStees of the Company land also ils directors lor the purposes of company lawl you
are responsible for the preparation ol the accounts in accordance with the requirements ol the
Companias Act 20061'lh& 2006 A¢l'l.
Having satisfied myself that the accounts of the Company are not required to be audited under Part
16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination
ol your charity's accounts as carried out under se¢lion 145 of the Charities Act 2011 {'Ihe 2011 Acl'l.
In carrying out my exarninalion I have followed the Directions given by the Charity Cofnmission under
section 14515llbl of the 2011 Act.
An independent examination does not involve gathering all the èvidence that would be required in an
audit and consequently does not cover all the matters that an auditor considers in giving their opinion
on Ihe accounts. The planning and conduct of an audit goes beyond the limited assurance Ihal an
independont examination Can provide. Consequently I express no opinion as lo whether the accounts
present a 'lrue and lair, view and my report is limited lo those specific matters sel out in Ihg
independent exarniner's sl8lemenl.
Independent examlner's statement
I have completed my examination. I confimi that no matters haye come to my attention in connection
with tho examination giving me causg to believe..
1. accounting rg¢ords were not kept in respect of Hannah's Willberry Wonder Pony Charity as
required by se¢tion 386 of the 2006 Act., or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirernents of section 396 of the 2006 Act
other than any requirement that the accc>unts give a 'true and fair view. which is not a matter
Considered as part of an indtspendenl examination,, or
4. the accounts have not been prepared in accordance wilh the methods and principles of the
Statemenl of Recommended Pra¢ti¢e for accounting and reporting by charities lapplicable to
charities preparing their accounts in accordance wlth the Financial Reporting Standard
applicable in the UK and Republic of Ireland {FRS 10211.
I hav& no concems and have come across no other matters in connection with the examination lo
which attention should be drawn in this report in order lo enable a proper understanding of the
accounts to bg reached.
Page 12

Hannah's Willberry Wonder Pony Charity
Independent Examiner's Report to the trustees of Hannah's Willberry
Wonder
ny Charity ('the Company,)
l Giessler FCA
ncis Clark LLP
Fr
Hitchcock House
Hilltop Park
Devizes Road
SalisbLJry
SP3 4UF
Dale..
P8ge 13

Hannah's Willberry Wonder Pony Charity
Statement of Financial Activities for the Year Ended 31 March 2024
(Including Income and Expenditure Account and Statement of Total
Recognised Gains and Losses)
Unrestricted
funds
Total
2024
Note
Income and Endowments from:
Donations and legacies
Investment income
123.497
33,012
123.497
33.012
Total income
156.509
156,509
Exp•ndltur8 on..
Charitable activities
72,879
72,879
Total expenditure
72,8791
72,879
Nel income
e3,630
83,630
Ngt movement in ftjnds
83,630
83,630
Re¢on¢lllation of funds
Totsl funds brought forward
1,535,357
1.535,357
Total funds carried fO￿ard
15
1,618,987
1,618,987
Unrestricted
funds
Total
2023
Not8
Income and Endowments from:
Donations and legacies
Investment income
91,346
12,267
91,346
12,267
Totsl income
103.613
103.613
Expandltura on:
Charitable activities
109,493
109,493
Total expenditure
1109,493
109,493
Nel expenditure
5,880
15.880
Nel movement in funds
15,880)
15,8801
Reconciliation of funds
Total funds brought forward
Total funds carried foTward
1.541.237
1,541,237
15
1.535,357
1.535,357
l of the charity's activities derive from continuing operations dudng the above two periods.
The funds breakdown for 2023 is shown in note 15.
Th8 notes on pages 17 10 23 form an integral part of th858 fin8ncial stat8m8nt5.
Page 14

Hannah's Willberry Wonder Pony Charity
Statement of Financial Activities for the Year Ended 31 March 2024
(Including Income and Expenditure Account and Statement of Total
Recognised Gains and Losses)
Unrastricted
funds
Total
2024
Note
In¢omo and Endowments from:
Donalions and legacies
Investment income
123,497
33,012
123.497
33,012
Total income
156,509
156,509
Ex￿ndIture on..
Charitable aclivilies
72,879
172,879
Tota5 expenditure
172,879
172,8791
Nel incorne
83,630
83,630
Nel movement in funds
83.630
83.630
Recon¢lliation of funds
Total funds brought forward
1,535.357
1.535,357
Total funds carfed foward
15
1,618,987
1.618,987
Unrestricted
funds
Total
2023
Not•
Income and Endowments from:
Donation5 and legacies
Inveslment income
91.346
12.267
91,346
12,267
Total income
103,613
103,613
Expandlture on..
Charitable activities
109,493
109,493
Total expenditure
109,493
109,493
Net expenditure
15,880
5,880
Net movement in funds
15,880)
15,8801
Reconciliation of funds
Total funds brought forward
Total funds carried forward
1,541,237
1.541.237
15
1,535,357
1.535.357
All of the charity's activities derive from conlinuirwJ operations during the above two peri¢xls.
The funds breakdown for 2023 is shown in note 15.
The notes on pages 17 to 23 form an integral part of Ih85e financial Statements.
Page 14

Hannah's Willberry Wonder Pony Charity
(Registration number: 10089069)
Balance Sheet as at 31 March 2024
2024
2023
Not•
Fixed as$trts
Investments
Current assets
Debtors
Cash al bank and in hand
10
27,638
1.605,355
12,837
1,543,324
1.632,993
1.556,161
Credltors: Amounts falllng due wlthln on¢ yoar
12
14,007
20,805
Net ¢urr¢nt as$ot$
1.618,986
1.535,356
Net a$$ets
1.618.987
1,535,357
Funds ofthe charfty:
Unrestrictèd incoma funds
Unreslricled funds
1.618.987
1.535,357
Total fund$
15
1,618,987
1,535.357
For the financial year ending 31 March 2024 the Charity was enliU8d lo extsmplion from audit under
section 477 of the Companies Act 2006 relating lo small companies.
Directors, responsibil+ties'.
The member5 have not required the charity lo obtain an audit of its accounts for the year in
question in accordance with section 476.. and
The directors a¢knO￿edge their responsibilities for complwng wllh the reqL¢lrements of the Act
respect lo accounting record5 and the preparation of accounts.
The fin
statements on pages 14 to 23 w8r8 approved by the trustèes, and authorised for issue
.L.¥and signed on their behalf by..
elers
Trustee
The notes on pages 17 10 23 fom an Integral part of these financial statements.
Page 15

Hannah's Willberry Wonder Pony Charity
Statement of Cash Flows for the Year Ended 31 March 2024
2024
2023
Not8
Cash flows from operatlng actlvltles
Nel cash incomellexpendilurel
83,630
15,880)
Adjustments lo cash flows from nonwcash Items
Investment income
133,012
50,618
12.267
118.1471
Worklng capltal adjustsnents
Ilncreaseydecrease in debtors
{Dee￿a$@yIn¢re8s8 in ¢rgdilors
10
12
114,8011
6.798
7,284
17,805
Ngt cash flows from operating activities
29,019
6,942
Cash flows from Investing a¢tivitie$
Interest receivable and similar income
33.012
12,267
Net increase in cash and ¢ash equivalents
62,031
19,209
Cash and cash equivalents at 1 April
1,543,324
1,524.115
Cash and cash equivalents al 31 March
1,605,355
1,543,324
All of the cash flow5 are derived from continuing operations during the above iwo periods.
Th8 notes on pages 1T io 23 form an Integral part of these financial staiements.
Page 16

Hannah's Willberry Wonder Pony Charity
Notes to the Financial Statements for the Year Ended 31 March 2024
1 Charlty status
The charity is litnited by guafanlee, incorporated in England and Wales, and consequently does not
have share capital. Each of the Iruslees is liable lo contribute an arnounl not exceeding £10 towards
Ihe assets of the charity in the event of liquidation.
The address of ils registered office is..
Manor Farm
Hemington
Radslock
BA3 5XX
2 Accounting policies
Summary of slgnlflcant accounting pollcles and key accountlng estlmates
The principal accounting policies applied in the preparation of these financial statements are sel out
below. These policies have been consistently applied to all the years presented, unless otherwise
staled.
statament of compllance
The financial slalemenls have been prepared in accordance wilh Accounting and Reporting by
Charities.. Statement of ReconTrmended Practice (applicable lo charities p￿paring their accounts in
accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS
10211 (issued in October 20191- (Charities SORP IFRS 10211. the Financial Reporting Standard
applicable in the UK and Republic of Ireland {FRS 1021 and the Companies Act 2006.
Basls of preparatlon
Hannah's Willberry Wonder Pony Charity meets the definition of a publlc benefit entity under FRS
102. Assets and liabilities are initially recognised al historical cost or transaction value unless
olheNise slated in the relevant accounting policy notes.
Golng concern
The trustees consider that there are no material uncertainties about the Charity's ability lo continue as
a going concom nor any significant areas of uncertainty Ihal affect the carying value of assets hgld by
the charity.
In¢om• and endowments
AJI income is recognised once the charity has enlillement lo the income, il is probable that the income
will be rgcèived and the amount of the income receivable can be measured reliably.
Donations and legacies
Donations and legacies are recognised on a receivable basis when receipt is probable 8nd the
amount can be reliably measured. Donations received through third party organisalions such as Just
Giving are shown nel of any fees charged by these organisalions.
Page 17

Hannah's Willberry Wonder Pony Charity
Notes to the Financial Statements for the Year Ended 31 March 2024
Expenditure
All exp&ndiluf8 is recognised once ther8 is a leg81 or constwctive obligation lo that expenditu￿, il is
probable settlement is required and the amount can be rneasured reliably. All costs are allocated lo
the applicable expenditure headirig that aggregate similar costs lo that category. Where costs cannot
be directly aitributed to particular headings they have been allocated on a basis consistent with tha
use of resources.
Charitable activitles
Charitsble expenditure comprises those costs incurred by th8 ¢harily in the delivery of ils activities
and services for ils beneficiaries. 11 includes both costs that can be allocated directly lo such activities
and those costs of an indirect nature necessary lo support them.
Grants
Grants are recognised al the amount payable when the intention lo make a grant has been
communicated to the recipient and the conditions of the gr8nl have been m81.
Governance costs
Thes& include the costs attributsble lo the charills compliance wth Constltutional and slalulory
requirements, including audit, strategic mana9emenl and Iruslees meetings and reimbursed
expenses.
Taxation
The ¢harlty is consldgr&d lo pass the 18sts $81 out in Paragraph 1 Scheclule 6 of the Financg A¢1 2010
and therefore it meets the definition of a charitable company for UK corporation lax purposes.
Accordingly, the charity is potentially exempl from laxalion in respect of income or capital gains
received within categories covered by Chapter 3 Part 11 01 the Corporation Tax Act 2010 or Section
256 of the Taxation of Chargeable Gains Act 1992, ￿ the extent that such income or gains are
applied exclusively lo ¢harilable purpos&s.
Fix&d a$$at Invèstm8nl$
Investments in subsidiaries are slated al historical cost sess provision for any diminution in value.
Cash and cash equlvalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-lerm highly
liquid investments that are readily convertible to a known amount of cash and are subject lo an
insignificant risk of change in value.
Fund structure
Unreslricled income funds are general funds that are available fof use al the trustees discretion in
furtherance of the objectives of the charity.
Page 18

Hannah's Willberry Wonder Pony Charity
Notes to the Financial Statements for the Year Ended 31 March 2024
3 Income from donatlons and lega¢les
Unrestricted
funds
Ggnoral
Total
funds
Don81ions and legacies.,
General (5onalions
Donation from trading subsidiary
99,059
24,438
99,059
24,438
Total for 2024
123,497
123,497
Total for 2023
91,346
91,346
4 Investment Income
Unrèstrictad
funds
Gènèral
Total
funds
Interest receivable and similar income.,
Interest re￿Ivable on bank deposits
33,012
33.012
Total for 2024
33,012
33,012
Total for 2023
12,267
12.267
5 Expenditure on charitable activltlès
Unrgstricted
funds
General
Total
funds
Note
Grant fijnding of activities
Alocaled support costs
Governance costs
59,573
7,544
5.762
59.573
7.544
5,762
Total for 2024
72,879
72,879
Total for 2023
109.493
109,493
In addition to the expenditure analysed above, there are also govemance costs of £5,762 12023
£4,213) which relate directly lo charitable aclivilies. See note 6 for further details.
Page 19

Hannah's Willberry Wonder Pony Charity
Notes to the Financial Statements for the Year Ended 31 March 2024
6 Analysls of govemancè and Support ¢o$t$
Charltablo a¢tlvities exp¢ndltur•
Unr•$trlct&d
Total
2024
Total
2023
General
Office expenses
Insurance
Legal and professional fees
Printing, postage and stationary
Bank fees
Govemance costs
IT related costs
2.000
1.227
35
2,000
1.227
35
1,618
545
44
2,073
4.213
3,448
5,762
830
3,448
5,762
830
13,306
13,306
8,493
Govornanc8 ca$ts
Unre$lrlcted
funds
General
Total
funds
Independent examiner fees
Examination of the financial slalements
Other fees paid lo examiners
2.915
2,847
2,915
2,847
Total for 2024
5.762
5,762
Total for 2023
4,213
4.213
7 Trustees remuneration and expenses
During the year the charity made the following transactions with Iruslees..
Two Iruslees received reimbursed travel and subsistence of £26712023 £1.3811 durin9 the year.
No trustees, nor any persons connected with them. have re￿ived any remuneration from the charity
during the year.
Pagè 20

Hannah's Willberry Wonder Pony Charity
Notes to the Financial Statements for the Year Ended 31 March 2024
8 Independent examinerfs remuneration
2024
2023
Examination of the financial slalemonts
2.915
2,650
Other fèes to examlners
l other services
2,847
1,563
9 Flx•d assgt Invo$tments
2024
2023
Shares in group undertakings and parbcipaling inlgr8sIs
Datalls of und8rtakings
D8tails of the investments in which the charity holds 20% or more of the nominal value of any dass of
share capital a￿ as follows..
Country ¢f
incorporation
Proportlon of votlng
rights and shares held
2024
2023
Prlnclpal
actlvlty
Undertaking
Holding
Subsldlary undertakings
Sale
of
merchandise
and soft toys
branded
with
Hannah's
Willberry
Wonder
Pony
The Willberry Wonder
Pony Trading
Company Limited
Manor Farm.
Heminglon,
Radslock,BA3 5XX
England and
Wales
Ordlnary
100%
100Q
Subsldlarles
Thè trading subsidiary Company donates ils profits lo the charity. For the period 1 April 2023 10 31
March 2024. the subsidiarls tumover was £42,000 12023 - £38.6021 and total expenditure wa5
£42.00012023 - £38,602>.
Page 21

Hannah's Willberry Wonder Pony Charity
Notes to the Financial Statements for the Year Ended 31 March 2024
10 D&btors
2024
2023
Due from group undertakings
27,638
12,837
11 Cash and cash equlval•nt$
2024
2023
Cash al bank
1,605,355
1.543,324
12 Creditors: amounts falllng due wlthln one year
2024
2023
Accruals
14,007
20,805
13 Analysls of net assets between funds
Unro$trl¢ted
fund$
General
Total funds
at 31 March
2024
Fixed asset investrnenls
Current assets
Current liabilities
1,632,993
14,0071
1,632,993
14,007
Total nel assets
1.618.987
1.618,987
Unr8strl¢t8d
funds
General
Tolal funds
at 31 March
2023
Fixed asset investments
CLJrrenl assets
Current liabilities
1,556.161
20.805
1.556.161
20,805
Total nel assets
1,535,357
1,535,357
14 Related party transactions
The charity ha5 taken advantage of the exemption in Financial Reporting Standards 102 chapter 33
"Relatgd Paty Disclosure. and has not disclosed transactions with wholly owned group unlertakings.
Donations made by the trustees wilhoul any conditions attached lotalled £415 12023 - £1501 for the
year.
Pag8 22

Hannah's Willberry Wonder Pony Charity
Notes to the Financial Statements for the Year Ended 31 March 2024
15 Funds
Balance at I
April 2023
Incoming
resources
Resources Balance at 31
expended
March 2024
Unrostrlctèd funds
General
1.535,357
156.509
72.879
1.618,987
Balance at 1
April 2022
Incomlng
resources
Resources Balance at 31
expended
March 2023
Unrestrl¢tgd funds
General
1,541,237
103,613
109.493
1,53S,357
P8g8 23